COLLEGIUM PHARMACEUTICAL, INC (COLL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q4 '17: 28.5M Q1 '18: 90.1M Q2 '18: 159.6M Q3 '18: 217.8M Q4 '18: 280.4M Q1 '19: 291.2M Q2 '19: 293.2M Q3 '19: 295.9M Q4 '19: 296.7M Q1 '20: 298.7M Q2 '20: 301.7M Q3 '20: 307.9M Q4 '20: 310M Q1 '21: 321.2M Q2 '21: 326.1M Q3 '21: 325.8M Q4 '21: 276.9M Q1 '22: 272.9M Q2 '22: 313.5M Q3 '22: 361.7M Q4 '22: 463.9M Q1 '23: 524.9M Q2 '23: 536.9M Q3 '23: 546.6M Q4 '23: 566.8M Q1 '24: 566.9M Q2 '24: 576.7M Q3 '24: 599.2M Q4 '24: 631.4M Q1 '25: 664.3M Q2 '25: 707M Q3 '25: 757.1M Q4 '25: 780.6M Q1 '26: 796.3M Q2 '26: 808.2M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 200M 400M 600M Q4 '19: 103M Q1 '20: 116.7M Q2 '20: 138.7M Q3 '20: 160.7M Q4 '20: 179.8M Q1 '21: 196.4M Q2 '21: 198.3M Q3 '21: 196.2M Q4 '21: 150.6M Q1 '22: 143.5M Q2 '22: 145.6M Q3 '22: 158.4M Q4 '22: 209.5M Q1 '23: 238.4M Q2 '23: 259.9M Q3 '23: 281.3M Q4 '23: 326.2M Q1 '24: 340.2M Q2 '24: 357.2M Q3 '24: 373.7M Q4 '24: 377.3M Q1 '25: 383.2M Q2 '25: 400.8M Q3 '25: 433.2M Q4 '25: 463.3M Q1 '26: 483.2M Q2 '26: 485.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating Income TTM

-140M -70M 0 70M 140M 210M Q4 '14: -17.7M Q1 '15: -17.6M Q2 '15: -18M Q3 '15: -20.8M Q4 '15: -26.9M Q1 '16: -38.9M Q2 '16: -58.8M Q3 '16: -75.9M Q4 '16: -94.1M Q1 '17: -101.7M Q2 '17: -98.5M Q3 '17: -85.4M Q4 '17: -75.4M Q1 '18: -65.5M Q2 '18: -51.5M Q3 '18: -49.3M Q4 '18: -20.7M Q1 '19: -17.5M Q2 '19: -15.2M Q3 '19: -10.4M Q4 '19: -23.7M Q1 '20: -8.7M Q2 '20: 12.9M Q3 '20: 38.9M Q4 '20: 56.2M Q1 '21: 72.4M Q2 '21: 72.2M Q3 '21: 66.7M Q4 '21: 17.6M Q1 '22: -13.6M Q2 '22: -18.9M Q3 '22: -12.6M Q4 '22: 33.3M Q1 '23: 68M Q2 '23: 92.5M Q3 '23: 117M Q4 '23: 167M Q1 '24: 191.8M Q2 '24: 203.6M Q3 '24: 193.5M Q4 '24: 169.9M Q1 '25: 142.1M Q2 '25: 129.7M Q3 '25: 157M Q4 '25: 179.6M Q1 '26: 188.8M Q2 '26: 157.4M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q4 '14: -17.9M Q1 '15: -17.8M Q2 '15: -18.4M Q3 '15: -21.2M Q4 '15: -27.3M Q1 '16: -39.2M Q2 '16: -59.1M Q3 '16: -76.1M Q4 '16: -94.2M Q1 '17: -101.6M Q2 '17: -98.2M Q3 '17: -85M Q4 '17: -74.9M Q1 '18: -70.4M Q2 '18: -62.4M Q3 '18: -65.6M Q4 '18: -39.1M Q1 '19: -30.2M Q2 '19: -21.8M Q3 '19: -11.4M Q4 '19: -22.7M Q1 '20: -12.6M Q2 '20: 198K Q3 '20: 17.6M Q4 '20: 26.8M Q1 '21: 42M Q2 '21: 106.7M Q3 '21: 103.5M Q4 '21: 71.5M Q1 '22: 42.8M Q2 '22: -35.2M Q3 '22: -42.8M Q4 '22: -25M Q1 '23: -29.4M Q2 '23: -11.2M Q3 '23: 9M Q4 '23: 48.2M Q1 '24: 93.3M Q2 '24: 99.9M Q3 '24: 88.6M Q4 '24: 69.2M Q1 '25: 43.9M Q2 '25: 36.3M Q3 '25: 58.4M Q4 '25: 62.9M Q1 '26: 74.9M Q2 '26: 47.9M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Cost of Revenue TTM

0 150M 300M 450M Q4 '17: 2.6M Q1 '18: 45.3M Q2 '18: 91.6M Q3 '18: 137M Q4 '18: 165.7M Q1 '19: 171.7M Q2 '19: 173.6M Q3 '19: 174.3M Q4 '19: 193.7M Q1 '20: 182M Q2 '20: 163.1M Q3 '20: 147.3M Q4 '20: 130.2M Q1 '21: 124.8M Q2 '21: 127.8M Q3 '21: 129.5M Q4 '21: 126.3M Q1 '22: 129.4M Q2 '22: 167.9M Q3 '22: 203.3M Q4 '22: 254.4M Q1 '23: 286.6M Q2 '23: 277.1M Q3 '23: 265.3M Q4 '23: 240.6M Q1 '24: 226.7M Q2 '24: 219.4M Q3 '24: 225.6M Q4 '24: 254.1M Q1 '25: 281.1M Q2 '25: 306.2M Q3 '25: 323.9M Q4 '25: 317.3M Q1 '26: 313.2M Q2 '26: 323.1M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-150M 0 150M 300M 450M Q4 '14: -17.9M Q1 '15: -15.9M Q2 '15: -18.1M Q3 '15: -20.2M Q4 '15: -21.6M Q1 '16: -31.4M Q2 '16: -47.8M Q3 '16: -60.7M Q4 '16: -75.1M Q1 '17: -87.2M Q2 '17: -83.9M Q3 '17: -77M Q4 '17: -67M Q1 '18: -13.7M Q2 '18: 59.4M Q3 '18: 113.8M Q4 '18: 169.4M Q1 '19: 131.2M Q2 '19: 90.2M Q3 '19: 54.4M Q4 '19: 27.8M Q1 '20: 29.7M Q2 '20: 58.9M Q3 '20: 87M Q4 '20: 93.9M Q1 '21: 121.2M Q2 '21: 106.9M Q3 '21: 89.9M Q4 '21: 103.6M Q1 '22: 57.7M Q2 '22: 68.6M Q3 '22: 94.1M Q4 '22: 124.2M Q1 '23: 177.2M Q2 '23: 236.5M Q3 '23: 267.7M Q4 '23: 274.7M Q1 '24: 309M Q2 '24: 276.7M Q3 '24: 193.7M Q4 '24: 205M Q1 '25: 198.4M Q2 '25: 203.5M Q3 '25: 290.9M Q4 '25: 329.3M Q1 '26: 331M Q2 '26: 329.9M Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

Free Cash Flow TTM

-150M 0 150M 300M 450M Q2 '17: -84.8M Q3 '17: -78.2M Q4 '17: -68M Q1 '18: -15M Q2 '18: 57.9M Q3 '18: 109.9M Q4 '18: 163.9M Q1 '19: 122.7M Q2 '19: 81.5M Q3 '19: 47.1M Q4 '19: 21.3M Q1 '20: 25.7M Q2 '20: 55M Q3 '20: 82.1M Q4 '20: 88.4M Q1 '21: 116M Q2 '21: 101.8M Q3 '21: 87M Q4 '21: 101.6M Q1 '22: 56M Q2 '22: 67.2M Q3 '22: 92.9M Q4 '22: 122.6M Q1 '23: 175.5M Q2 '23: 235.2M Q3 '23: 266.5M Q4 '23: 274.3M Q1 '24: 308.2M Q2 '24: 275.6M Q3 '24: 192.4M Q4 '24: 203.3M Q1 '25: 196.6M Q2 '25: 201.8M Q3 '25: 289.3M Q4 '25: 327.6M Q1 '26: 329.8M Q2 '26: 328.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '14: 912.6K Q1 '15: 7.6M Q2 '15: 11.8M Q3 '15: 20.5M Q4 '15: 20.6M Q1 '16: 23.1M Q1 '18: 32.9M Q2 '18: 33M Q3 '18: 33M Q4 '18: 33.8M Q1 '19: 33.3M Q2 '19: 33.4M Q3 '19: 33.5M Q1 '20: 35.1M Q2 '20: 35.1M Q3 '20: 35.1M Q4 '20: 35.4M Q1 '21: 41.2M Q2 '21: 41.3M Q3 '21: 36.3M Q4 '21: 34.1M Q1 '22: 33.7M Q2 '22: 34M Q3 '22: 34.6M Q4 '22: 33.6M Q1 '23: 34.3M Q2 '23: 42.8M Q3 '23: 42.1M Q4 '23: 41.3M Q1 '24: 41.4M Q2 '24: 40.4M Q3 '24: 40.2M Q4 '24: 40.1M Q1 '25: 32.8M Q2 '25: 39.1M Q3 '25: 39.4M Q4 '25: 40.1M Q1 '26: 40.1M Q2 '26: 32.5M Q3 '15 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-24.00 -16.00 -8.00 0.00 8.00 16.00 24.00 Q4 '14: -22.71 Q1 '15: -18.33 Q2 '15: -13.45 Q3 '15: -6.06 Q4 '15: -2.02 Q1 '16: -2.05 Q2 '16: -2.65 Q3 '16: -3.32 Q4 '16: -3.88 Q1 '17: -3.99 Q2 '17: -3.66 Q3 '17: -2.98 Q4 '17: -2.50 Q1 '18: -2.28 Q2 '18: -1.96 Q3 '18: -2.01 Q4 '18: -1.20 Q1 '19: -0.92 Q2 '19: -0.66 Q3 '19: -0.34 Q4 '19: -0.67 Q1 '20: -0.37 Q2 '20: -0.00 Q3 '20: 0.50 Q4 '20: 0.76 Q1 '21: 1.16 Q2 '21: 2.72 Q3 '21: 2.62 Q4 '21: 1.69 Q1 '22: 0.89 Q2 '22: -1.05 Q3 '22: -1.26 Q4 '22: -0.74 Q1 '23: -0.86 Q2 '23: -0.37 Q3 '23: 0.15 Q4 '23: 1.18 Q1 '24: 2.40 Q2 '24: 2.58 Q3 '24: 2.32 Q4 '24: 1.86 Q1 '25: 1.22 Q2 '25: 1.04 Q3 '25: 1.61 Q4 '25: 1.71 Q1 '26: 2.04 Q2 '26: 1.24 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.